FDA Inspection
Ajanta Pharma Ltd.Ajanta Pharma Ltd. – FDA Inspection, Feb 7, 2017
Record Details
This FDA Inspection record concerns Ajanta Pharma Ltd., with an inspection on February 7, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 69d66c75-a99f-42cb-bbb1-29c81e157e1a
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1009806
- FDA center
- Human Drugs
- Project area
- Generic Drug Evaluation
- Outcome
- Form 483 issued
FDA Citations
1- 21 CFR 211.63Equipment Design, Size and Location
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Ajanta Pharma Ltd.
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 21, 2026 | Not classified | Office of Inspections and Investigations | Drug Quality Assurance |
| March 5, 2024 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| June 28, 2019 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| March 20, 2015 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 6, 2012 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Ajanta Pharma Ltd.
- FDA Inspection 1313426 - 2026-04-21
- FDA Inspection 1235564 - 2024-03-05
- FDA Inspection 1097061 - 2019-06-28
- FDA Inspection 917795 - 2015-03-20
- FDA Inspection 801522 - 2012-09-06
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.